Boai NKY Medical Holdings Ltd. (SHE:300109)

Market Cap	8.41B
Revenue (ttm)	1.54B
Net Income (ttm)	308.71M
Shares Out	484.70M
EPS (ttm)	0.64
PE Ratio	27.12
Forward PE	n/a
Dividend	0.25 (1.41%)
Ex-Dividend Date	Jun 7, 2024

Volume	11,219,044
Average Volume	11,140,585
Open	16.19
Previous Close	17.69
Day's Range	16.19 - 17.87
52-Week Range	9.76 - 18.98
Beta	-0.08
RSI	61.09
Earnings Date	Aug 29, 2025

About Boai NKY Medical Holdings

Boai NKY Medical Holdings Ltd. engages in the fine chemical and medical care businesses in China and internationally. The company offers polyvinylpyrrolidone (PVP) series products, and vinyl methyl ether and maleic acid products; anhydride copolymer (PVME/MA) series products; GBL, 2-pyrrolidone, NVP monomer, PVPK series (povidone), copovidone, and other VP/VA copolymer series products; and PVPP (cross-linked povidone), PVP-I, and related pharmaceutical intermediates. Its products are used in chemical, pharmaceutical, brewing and beverage, pigme...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1987
• Employees: 1,163
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300109

Financial Performance

In 2024, Boai NKY Medical Holdings's revenue was 1.61 billion, an increase of 1.45% compared to the previous year's 1.58 billion. Earnings were 349.68 million, a decrease of -29.07%.